
163.26 Delayed Data As of Jan 22 | ![]() Today’s Change | 90.14 Today|||52-Week Range 176.64 | -1.35% Year-to-Date |
GRFS or ZTS: Which Is the Better Value Stock Right Now? Jan 12 / Zacks.com - Paid Partner Content |
Previous close | 164.46 |
Today’s open | 164.54 |
Day’s range | 162.66 - 165.22 |
Volume | 1,079,071 |
Average volume (3 months) | 1,690,276 |
Market cap | $77.6B |
Earnings growth (last year) | +6.13% |
Earnings growth (this year) | +4.24% |
Earnings growth (next 5 years) | +10.47% |
Revenue growth (last year) | +7.47% |
P/E ratio | 47.1 |
Price/Sales | 10.19 |
Price/Book | 28.68 |
Next reporting date | February 16, 2021 |
EPS forecast (this quarter) | $0.86 |
Annual revenue (last year) | $6.3B |
Annual profit (last year) | $1.5B |
Net profit margin | 23.96% |
Sector Health Technology |
Industry Pharmaceuticals: Generic |
No executives to display |
Corporate headquarters Parsippany, New Jersey |